Your landlord has just raised your rent by 10% and your mind starts running the numbers—should you cop it sweet or look to ...
Ksana, Vansoho Development’s planned new development in Port Moody, will strike a balance between contemporary living and ...
Social media site Bluesky has gained 1 million new users in the week since the U.S. election, as some X users look for an ...
Even less in the Seven Bucks wheelhouse (and devoid of a Johnson performance) is an upcoming documentary feature about ...
Welcome back to Critical Materials, your daily roundup for all things EV and automotive tech. Today, we're chatting about ...
ClickFix, a new scam targeting computer users, is on the rise in the U.S. The scam prompts its targets to click on a link to ...
Toast added 7,000 new locations in the third quarter, adding up to a 28% increase year over year for a total of 127,000. Annualized recurring run-rate, which is its preferred top-line metric, ...
Disney (DIS), one of the oldest and most beloved entertainment brands in the world, is set to report its fiscal ...
Customized perks, AI-driven solutions and even freelance employees are all in play at banks as human resource managers ...
Unscripted producers from the U.S. are seeing international business as a route out of the work-for-hire drought in the ...
Cabot Corporation's 50% return exceeds expectations, but its valuation raises concerns. Find out why CBT stock is a "Hold" ...
Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.